IDEXX Laboratories, Inc. (IDXX)

NASDAQ: IDXX · IEX Real-Time Price · USD
539.93
+0.36 (0.07%)
At close: Mar 28, 2024, 4:00 PM
540.21
+0.28 (0.05%)
After-hours: Mar 28, 2024, 6:47 PM EDT

Company Description

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally.

The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.

It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community.

In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits.

Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E.

coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups.

Additionally, the company offers human medical point-of-care products and laboratory diagnostics services.

The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers.

IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories, Inc.
IDEXX Laboratories logo
Country United States
IPO Date Jun 21, 1991
Industry Diagnostics & Research
Sector Healthcare
Employees 11,000
CEO Jonathan J. Mazelsky

Contact Details

Address:
One Idexx Drive
Westbrook, Maine 04092-2041
United States
Phone (207) 556-0300
Website idexx.com

Stock Details

Ticker Symbol IDXX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000874716
CUSIP Number 45168D104
ISIN Number US45168D1046
Employer ID 01-0393723
SIC Code 2835

Key Executives

Name Position
Jonathan J. Mazelsky President, Chief Executive Officer and Director
Brian P. McKeon Chief Financial Officer, Executive Vice President and Treasurer
James F. Polewaczyk Executive Vice President and Chief Commercial Officer
Michael J. Lane Executive Vice President and GM of Reference Laboratories and Information Technology
Dr. Nimrata Khatra Hunt P.E., Ph.D. Executive Vice President of Strategy, Sector Development and Global Operations
John Hart Senior Vice President of Global Operations
Jeffery D. Chadbourne Senior Vice President of Commercial Finance and Sales Operations
Dr. Martin Smith Ph.D. Executive Vice President and Chief Technology Officer
Ken Grady Senior Vice President and Chief Information Officer
Sharon E. Underberg Executive Vice President, General Counsel, and Corporate Secretary

Latest SEC Filings

Date Type Title
Mar 27, 2024 ARS Filing
Mar 27, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 27, 2024 DEF 14A Other definitive proxy statements
Mar 6, 2024 144 Filing
Mar 5, 2024 144 Filing
Feb 22, 2024 10-K Annual Report
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 8, 2024 144 Filing
Feb 7, 2024 144 Filing
Feb 7, 2024 144 Filing